# An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

> **NCT01716221** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 1 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** bupropion & Citalopram
- **DRUG:** Bupropion & Placebo
- **DRUG:** Placebo & Citalopram
- **DRUG:** Placebo & Placebo

## Key facts

- **NCT ID:** NCT01716221
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2016-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716221, "An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01716221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*